Streetbeat News

Products Services

PINS

Pinterest Inc (NYSE:PINS) shares surged after reporting strong Q1 earnings and upbeat guidance. Revenue hit $740 million, surpassing estimates of $699.872 million, with a smaller-than-expected EPS loss of 4 cents. Year-over-year, revenues grew nearly 23%, and global monthly active users reached a record 518 million. CEO Bill Ready highlighted significant growth and advancements in AI and shoppability. Q2 revenue is expected to be between $835 million to $850 million, exceeding forecasts. Rosenblatt analyst Barton Crockett upgraded the price target from $45 to $48.

Portfolio Pulse from Adam Eckert

May 01, 2024 | 1:32 pm

GEHC

GE HealthCare has announced the launch of its Revolution RT CT solution, marking a significant advancement in its healthcare technology offerings. This new product is expected to enhance the company's position in the healthcare technology market by providing state-of-the-art imaging solutions.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:30 pm

AMZN

Amazon.com Inc (NASDAQ:AMZN) reported a Q1 revenue of $143.3 billion, a 13% increase year-over-year, surpassing estimates with earnings per share at 98 cents. The growth was driven by AWS and its international business, with AWS revenue growing 17%. JPMorgan analyst Doug Anmuth maintains an Overweight rating on Amazon, raising the price target from $225 to $240, based on future free cash flow estimates. Anmuth highlights Amazon's potential for profit growth, driven by AWS and GenAI services, and anticipates a multi-billion-dollar revenue run-rate from GenAI services. Despite a 3.29% drop in stock price on Tuesday, Amazon's stock was up 3.8% in premarket trading following the earnings beat.

Portfolio Pulse from Surbhi Jain

May 01, 2024 | 1:27 pm

RBLX

Integral Ad Science (IAS) has announced an integration with Roblox, aiming to enhance advertising safety and effectiveness on the Roblox platform. This partnership will leverage IAS's technology to provide advertisers with improved tools for ad verification and optimization on Roblox, a popular online gaming platform.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:21 pm

PSTX

Astellas and Poseida Therapeutics have announced a research collaboration and license agreement to develop novel allogeneic cell therapies for oncology, focusing on solid tumors using Poseida's proprietary allogeneic CAR-T platform.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:15 pm

ARW

Arrow Electronics has been selected by Broadcom as the sole provider for its CloudHealth offering. This exclusive partnership positions Arrow Electronics (ARW) at the forefront of distributing Broadcom's CloudHealth solutions, potentially enhancing ARW's market position and revenue streams from cloud services.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:15 pm

VVX

V2X, a company specializing in vehicle-to-everything communication technologies, has announced receiving $75 million in new and follow-on orders. This significant financial milestone underscores the growing demand for V2X solutions in the automotive and smart city sectors, potentially signaling an upward trajectory for the company's financial health and market position.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:13 pm

MULN

Mullen Automotive, Inc. has expanded its dealer network by adding Pritchard EV, a move aimed at enhancing its distribution and sales capabilities in the electric vehicle (EV) market. This partnership is expected to leverage Pritchard EV's established presence and expertise in the automotive industry to boost Mullen's market penetration and customer reach.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:11 pm

BZH

Beazer Homes has acquired 174 acres in Marietta, Georgia, with plans to develop 591 homes. This strategic acquisition aims to expand Beazer Homes' footprint in the region and capitalize on the growing demand for residential properties.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:09 pm

CTMX

CytomX Therapeutics announced it will provide an initial update on the Phase 1a clinical data for CX-904 on May 8, 2024. This update is highly anticipated as it marks a significant milestone in the development of CX-904.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:08 pm